AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
Log in

NASDAQ:FWPForward Pharma A/S Stock Price, Forecast & News

$6.30
-0.07 (-1.10 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.21
Now: $6.30
$6.41
50-Day Range
$5.83
MA: $6.19
$7.17
52-Week Range
$4.61
Now: $6.30
$12.72
Volume11,800 shs
Average Volume110,194 shs
Market Capitalization$42.78 million
P/E RatioN/A
Dividend YieldN/A
Beta2.08
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.
Read More
Forward Pharma A/S logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.69 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FWP
CUSIPN/A
Phone0114533444242

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.25 billion
Book Value$11.42 per share

Profitability

Miscellaneous

Employees5
Market Cap$42.78 million
Next Earnings DateN/A
OptionableNot Optionable

Receive FWP News and Ratings via Email

Sign-up to receive the latest news and ratings for FWP and its competitors with MarketBeat's FREE daily newsletter.

Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions

How has Forward Pharma A/S's stock been impacted by COVID-19 (Coronavirus)?

Forward Pharma A/S's stock was trading at $5.55 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, FWP shares have increased by 13.5% and is now trading at $6.30. View which stocks have been most impacted by Coronavirus.

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) posted its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by $0.06. View Forward Pharma A/S's earnings history.

Has Forward Pharma A/S been receiving favorable news coverage?

Media coverage about FWP stock has trended negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Forward Pharma A/S earned a daily sentiment score of -2.3 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Forward Pharma A/S.

Who are some of Forward Pharma A/S's key competitors?

What other stocks do shareholders of Forward Pharma A/S own?

Who are Forward Pharma A/S's key executives?

Forward Pharma A/S's management team includes the following people:
  • Mr. Florian Schonharting, Co-Founder & Chairman (Age 50)
  • Dr. Claus Bo Svendsen, CEO & Principal Financial Officer (Age 42)
  • Mr. Thomas Carbone, Principal Accounting Officer (Age 62)

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

How do I buy shares of Forward Pharma A/S?

Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $6.30.

How big of a company is Forward Pharma A/S?

Forward Pharma A/S has a market capitalization of $42.78 million and generates $1.25 billion in revenue each year. Forward Pharma A/S employs 5 workers across the globe.

What is Forward Pharma A/S's official website?

The official website for Forward Pharma A/S is www.forward-pharma.com.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 0114533444242 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.